These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10454874)

  • 1. The use of olanzapine for movement disorder in Huntington's disease: a first case report.
    Dipple HC
    J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):123-4. PubMed ID: 10454874
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine and Huntington's disease.
    Bogelman G; Hirschmann S; Modai I
    J Clin Psychopharmacol; 2001 Apr; 21(2):245-6. PubMed ID: 11270928
    [No Abstract]   [Full Text] [Related]  

  • 3. Improvement of Huntington's disease with olanzapine and valproate.
    Grove VE; Quintanilla J; DeVaney GT
    N Engl J Med; 2000 Sep; 343(13):973-4. PubMed ID: 11012330
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine. Case report.
    Etchebehere EC; Lima MC; Passos W; Maciel Júnior JA; Santos AO; Ramos CD; Camargo EE
    Arq Neuropsiquiatr; 1999 Sep; 57(3B):863-6. PubMed ID: 10751925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine for Huntington's disease: an open label study.
    Bonelli RM; Mahnert FA; Niederwieser G
    Clin Neuropharmacol; 2002; 25(5):263-5. PubMed ID: 12410058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose olanzapine in Huntington's disease.
    Bonelli RM; Niederwieser G; Tribl GG; Költringer P
    Int Clin Psychopharmacol; 2002 Mar; 17(2):91-3. PubMed ID: 11890191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole and olanzapine in Huntington's disease.
    Bonelli RM; Niederwieser G; Diez J; Költringer P
    Eur J Neurol; 2002 Mar; 9(2):183-4. PubMed ID: 11882065
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid onset of tardive dyskinesia in Huntington disease with olanzapine.
    Benazzi F
    J Clin Psychopharmacol; 2002 Aug; 22(4):438-9. PubMed ID: 12172349
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine-associated seizure.
    Bonelli RM
    Ann Pharmacother; 2003 Jan; 37(1):149-50. PubMed ID: 12503952
    [No Abstract]   [Full Text] [Related]  

  • 10. [Olanzapine improves chorea in patients with Huntington's disease].
    Jiménez-Jiménez FJ; de Toledo M; Puertas I; Barón M; Zurdo M; Barcenilla B
    Rev Neurol; 2002 Sep 16-30; 35(6):524-5. PubMed ID: 12389168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of olanzapine in Huntington disease.
    Squitieri F; Cannella M; Porcellini A; Brusa L; Simonelli M; Ruggieri S
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):69-72. PubMed ID: 11234911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine in Huntington's disease.
    Paleacu D; Anca M; Giladi N
    Acta Neurol Scand; 2002 Jun; 105(6):441-4. PubMed ID: 12027832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of tardive dyskinesia following switch from neuroleptics to olanzapine.
    Lykouras L; Agelopoulos E; Tzavellas E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):815-7. PubMed ID: 12188112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report.
    Grant JE
    J Clin Psychiatry; 2001 Apr; 62(4):297-8. PubMed ID: 11379848
    [No Abstract]   [Full Text] [Related]  

  • 15. Usefulness of olanzapine in refractory panic attacks.
    Khaldi S; Kornreich C; Dan B; Pelc I
    J Clin Psychopharmacol; 2003 Feb; 23(1):100-1. PubMed ID: 12544382
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluoxetine augmentation with olanzapine for treatment of chronic resistant depression in an elderly patient: a case report.
    Detweiler MB; Trinkle DB
    J Clin Psychiatry; 2003 Jul; 64(7):851-2. PubMed ID: 12934994
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine augmentation for trichotillomania.
    Ashton AK
    Am J Psychiatry; 2001 Nov; 158(11):1929-30. PubMed ID: 11691706
    [No Abstract]   [Full Text] [Related]  

  • 18. Apraxia of eyelid closure in Huntington's disease.
    Bonelli RM; Niederwieser G
    J Neural Transm (Vienna); 2002 Feb; 109(2):197-201. PubMed ID: 12075860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and motor response to low dose olanzapine in Huntington's disease: case report.
    Laks J; Rocha M; Capitão C; Domingues RC; Ladeia G; Lima M; Engelhardt E
    Arq Neuropsiquiatr; 2004 Dec; 62(4):1092-4. PubMed ID: 15608976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine in the treatment of psychotic depression.
    Malhi GS; Checkley SA
    Br J Psychiatry; 1999 May; 174():460. PubMed ID: 10616618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.